Leerink Partners Initiates Coverage on Boston Scientific (NYSE:BSX)
Leerink Partners assumed coverage on shares of Boston Scientific (NYSE:BSX – Free Report) in a report issued on Monday, MarketBeat.com reports. The firm issued an outperform rating and a $118.00 price target on the medical equipment provider’s stock. A number of other research analysts also recently commented on BSX. Evercore ISI increased their target price […]
Leerink Partners assumed coverage on shares of Boston Scientific (NYSE:BSX – Free Report) in a report issued on Monday, MarketBeat.com reports. The firm issued an outperform rating and a $118.00 price target on the medical equipment provider’s stock. A number of other research analysts also recently commented on BSX. Evercore ISI increased their target price […]
